Immediate and delayed effects of subchronic Paraquat exposure during an early differentiation stage in 3D-rat brain cell cultures

Toxicology Letters

Volumn 230, Issue 2, 2014, Pages 188-197

  Sandström von Tobel, Jenny ^a,b   Zoia, Debora ^b   Althaus, Jorane ^b   Antinori, Paola ^a,c   Mermoud, Julien ^b   Pak, Hui Song ^c   Scherl, Alexander ^a,c   Monnet Tschudi, Florianne ^a,b  

^a Swiss Centre for Applied Human Toxicology   (Switzerland)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

^c UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

Astrogliosis; M1 M2 phenotype; Microglial activation; Neuroinflammation; Paraquat dichloride

Indexed keywords

PARAQUAT; CYTOKINE; HERBICIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTOSIS; BRAIN CELL CULTURE; CELL STRUCTURE; CONTROLLED STUDY; EMBRYO; FETUS; LONG TERM EXPOSURE; MICROGLIA; NERVE CELL; NERVE CELL DIFFERENTIATION; NERVE DEGENERATION; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; RAT; ANIMAL; ASTROCYTE; BRAIN; CELL CULTURE; CHEMICALLY INDUCED; CYTOLOGY; DEGENERATIVE DISEASE; DOSE RESPONSE; DRUG EFFECTS; GENETICS; SPRAGUE DAWLEY RAT; TOXICITY;

ANIMALS; ASTROCYTES; BRAIN; CELLS, CULTURED; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; HERBICIDES; MICROGLIA; NEURODEGENERATIVE DISEASES; NEURONS; PARAQUAT; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84907169600     PISSN: 03784274     EISSN: 18793169     Source Type: Journal    
DOI: 10.1016/j.toxlet.2014.02.001     Document Type: Article

References (81)

1. Anderson C.M., Swanson R.A. Astrocyte glutamate transport: review of properties, regulation, and physiological functions. Glia 2000, 32:1-14.
2. Aschner M. Astrocytes as mediators of immune and inflammatory responses in the CNS. Neurotoxicology 1998, 19:269-281.
3. Barnum C.J., Tansey M.G. Modeling neuroinflammatory pathogenesis of Parkinson's disease. Progress in Brain Research 2010, 184:113-132.
4. Barone E., Di Domenico F., Cenini G., Sultana R., Coccia R., Preziosi P., Perluigi M., Mancuso C., Butterfield D.A. Oxidative and nitrosative modifications of biliverdin reductase-A in the brain of subjects with Alzheimer's disease and amnestic mild cognitive impairment. Journal of Alzheimer's Disease: JAD 2011, 25:623-633.
5. Benson D.L., Mandell J.W., Shaw G., Banker G. Compartmentation of alpha-internexin and neurofilament triplet proteins in cultured hippocampal neurons. Journal of Neurocytology 1996, 25:181-196.
6. Berry C., La Vecchia C., Nicotera P. Paraquat and Parkinson's disease. Cell Death and Differentiation 2010, 17:1115-1125.
7. Blandini F. Neural and immune mechanisms in the pathogenesis of Parkinson's disease. Journal of Neuroimmune Pharmacology: the Official Journal of the Society on NeuroImmune Pharmacology 2013, 8:189-201.
8. Blesa J., Phani S., Jackson-Lewis V., Przedborski S. Classic and new animal models of Parkinson's disease. Journal of Biomedicine & Biotechnology 2012, 845618.
9. Bonneh-Barkay D., Reaney S.H., Langston W.J., Di Monte D.A. Redox cycling of the herbicide paraquat in microglial cultures. Brain Research Molecular Brain Research 2005, 134:52-56.
10. Brissoni B., Agostini L., Kropf M., Martinon F., Swoboda V., Lippens S., Everett H., Aebi N., Janssens S., Meylan E., Felberbaum-Corti M., Hirling H., Gruenberg J., Tschopp J., Burns K. Intracellular trafficking of interleukin-1 receptor I requires Tollip. Current biology: CB 2006, 16:2265-2270.
11. Calhoun M.E., Jucker M., Martin L.J., Thinakaran G., Price D.L., Mouton P.R. Comparative evaluation of synaptophysin-based methods for quantification of synapses. Journal of Neurocytology 1996, 25:821-828.
12. Capaldi R.A. Structure and function of cytochrome c oxidase. Annual Review of Biochemistry 1990, 59:569-596.
13. Chen Q., Niu Y., Zhang R., Guo H., Gao Y., Li Y., Liu R. The toxic influence of paraquat on hippocampus of mice: involvement of oxidative stress. Neurotoxicology 2010, 31:310-316.
14. Cicchetti F., Drouin-Ouellet J., Gross R.E. Environmental toxins and Parkinson's disease: what have we learned from pesticide-induced animal models?. Trends in Pharmacological Sciences 2009, 30:475-483.
15. Colton C., Wilcock D.M. Assessing activation states in microglia. CNS & Neurological Disorders Drug Targets 2010, 9:174-191.
16. Colton C.A. Heterogeneity of microglial activation in the innate immune response in the brain. Journal of Neuroimmune Pharmacology: the Official Journal of the Society on NeuroImmune Pharmacology 2009, 4:399-418.
17. Costello S., Cockburn M., Bronstein J., Zhang X., Ritz B. Parkinson's disease and residential exposure to maneb and paraquat from agricultural applications in the central valley of California. American Journal of Epidemiology 2009, 169:919-926.
18. De Camilli P., Cameron R., Greengard P. Synapsin I (protein I), a nerve terminal-specific phosphoprotein. I. Its general distribution in synapses of the central and peripheral nervous system demonstrated by immunofluorescence in frozen and plastic sections. The Journal of Cell Biology 1983, 96:1337-1354.
19. Debernardi R., Pierre K., Lengacher S., Magistretti P.J., Pellerin L. Cell-specific expression pattern of monocarboxylate transporters in astrocytes and neurons observed in different mouse brain cortical cell cultures. Journal of Neuroscience Research 2003, 73:141-155.
20. Defaux A., Zurich M.G., Honegger P., Monnet-Tschudi F. Minocycline promotes remyelination in aggregating rat brain cell cultures after interferon-gamma plus lipopolysaccharide-induced demyelination. Neuroscience 2011, 187:84-92.
21. Dong Y., Benveniste E.N. Immune function of astrocytes. Glia 2001, 36:180-190.
22. Eng L.F., Ghirnikar R.S., Lee Y.L. Glial fibrillary acidic protein: GFAP-thirty-one years (1969-2000). Neurochemical Research 2000, 25:1439-1451.
23. Esclapez M., Tillakaratne N.J., Kaufman D.L., Tobin A.J., Houser C.R. Comparative localization of two forms of glutamic acid decarboxylase and their mRNAs in rat brain supports the concept of functional differences between the forms. The Journal of Neuroscience: the Official Journal of the Society for Neuroscience 1994, 14:1834-1855.
24. Freire C., Koifman S. Pesticide exposure and Parkinson's disease: epidemiological evidence of association. Neurotoxicology 2012, 33:947-971.
25. Fritschy J.M., Meskenaite V., Weinmann O., Honer M., Benke D., Mohler H. GABAB-receptor splice variants GB1a and GB1b in rat brain: developmental regulation, cellular distribution and extrasynaptic localization. The European Journal of Neuroscience 1999, 11:761-768.
26. Fuster-Matanzo A., Llorens-Martin M., Jurado-Arjona J., Avila J., Hernandez F. Tau protein and adult hippocampal neurogenesis. Frontiers in Neuroscience 2012, 6:104.
27. Gomez C., Bandez M.J., Navarro A. Pesticides and impairment of mitochondrial function in relation with the parkinsonian syndrome. Frontiers in Bioscience: a Journal and Virtual Library 2007, 12:1079-1093.
28. Greengard P., Valtorta F., Czernik A.J., Benfenati F. Synaptic vesicle phosphoproteins and regulation of synaptic function. Science 1993, 259:780-785.
29. 2+ -triggered exocytosis. Science 2004, 304:289-292.
30. Hayes J.D., Pulford D.J. The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Critical Reviews in Biochemistry and Molecular Biology 1995, 30:445-600.
31. Hicks A., Davis S., Rodger J., Helme-Guizon A., Laroche S., Mallet J. Synapsin I and syntaxin 1B: key elements in the control of neurotransmitter release are regulated by neuronal activation and long-term potentiation in vivo. Neuroscience 1997, 79:329-340.
32. Honegger P., Defaux A., Monnet-Tschudi F., Zurich M.G. Preparation, maintenance, and use of serum-free aggregating brain cell cultures. Methods in Molecular Biology 2011, 758:81-97.
33. Jacque C.M., Vinner C., Kujas M., Raoul M., Racadot J., Baumann N.A. Determination of glial fibrillary acidic protein (GFAP) in human brain tumors. Journal of the Neurological Sciences 1978, 35:147-155.
34. Khwaja M., McCormack A., McIntosh J.M., Di Monte D.A., Quik M. Nicotine partially protects against paraquat-induced nigrostriatal damage in mice; link to alpha6beta2* nAChRs. Journal of Neurochemistry 2007, 100:180-190.
35. Kigerl K.A., Gensel J.C., Ankeny D.P., Alexander J.K., Donnelly D.J., Popovich P.G. Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. The Journal of Neuroscience: the Official Journal of the Society for Neuroscience 2009, 29:13435-13444.
36. Klintworth H., Garden G., Xia Z. Rotenone and paraquat do not directly activate microglia or induce inflammatory cytokine release. Neuroscience Letters 2009, 462:1-5.
37. Koh J.Y., Choi D.W. Quantitative determination of glutamate mediated cortical neuronal injury in cell culture by lactate dehydrogenase efflux assay. Journal of Neuroscience Methods 1987, 20:83-90.
38. Kreutzberg G.W. Microglia: a sensor for pathological events in the CNS. Trends in Neurosciences 1996, 19:312-318.
39. Kuter K., Smialowska M., Wieronska J., Zieba B., Wardas J., Pietraszek M., Nowak P., Biedka I., Roczniak W., Konieczny J., Wolfarth S., Ossowska K. Toxic influence of subchronic paraquat administration on dopaminergic neurons in rats. Brain Research 2007, 1155:196-207.
40. Landrigan P.J., Sonawane B., Butler R.N., Trasande L., Callan R., Droller D. Early environmental origins of neurodegenerative disease in later life. Environmental Health Perspectives 2005, 113:1230-1233.
41. Liao B., Zhao W., Beers D.R., Henkel J.S., Appel S.H. Transformation from a neuroprotective to a neurotoxic microglial phenotype in a mouse model of ALS. Experimental Neurology 2012, 237:147-152.
42. Liou H.H., Chen R.C., Tsai Y.F., Chen W.P., Chang Y.C., Tsai M.C. Effects of paraquat on the substantia nigra of the wistar rats: neurochemical, histological, and behavioral studies. Toxicology and Applied Pharmacology 1996, 137:34-41.
43. Liska D.J. The detoxification enzyme systems. Alternative Medicine Review: a Journal of Clinical Therapeutic 1998, 3:187-198.
44. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408.
45. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. The Journal of Biological Chemistry 1951, 193:265-275.
46. Magnoni R., Palmfeldt J., Hansen J., Christensen J.H., Corydon T.J., Bross P. The Hsp60 folding machinery is crucial for manganese superoxide dismutase folding and function. Free Radical Research 2014, 48:168-179.
47. Mangano E.N., Litteljohn D., So R., Nelson E., Peters S., Bethune C., Bobyn J., Hayley S. Interferon-gamma plays a role in paraquat-induced neurodegeneration involving oxidative and proinflammatory pathways. Neurobiology of Aging 2012, 33:1411-1426.
48. Maximov A., Sudhof T.C. Autonomous function of synaptotagmin 1 in triggering synchronous release independent of asynchronous release. Neuron 2005, 48:547-554.
49. McArthur S., Cristante E., Paterno M., Christian H., Roncaroli F., Gillies G.E., Solito E. Annexin A1: a central player in the anti-inflammatory and neuroprotective role of microglia. Journal of Immunology 2010, 185:6317-6328.
50. Monnet-Tschudi F., Zurich M.G., Honegger P. Neurotoxicant-induced inflammatory response in three-dimensional brain cell cultures. Human & Experimental Toxicology 2007, 26:339-346.
51. Nakamura H. Thioredoxin and its related molecules: update 2005. Antioxidants & Redox Signaling 2005, 7:823-828.
52. Ni B., Du Y., Wu X., DeHoff B.S., Rosteck P.R., Paul S.M. Molecular cloning, expression, and chromosomal localization of a human brain-specific Na(+)-dependent inorganic phosphate cotransporter. Journal of Neurochemistry 1996, 66:2227-2238.
53. Nishimura Y., Hayashi M., Inada H., Tanaka T. Molecular cloning and characterization of mammalian homologues of vesicle-associated membrane protein-associated (VAMP-associated) proteins. Biochemical and Biophysical Research Communications 1999, 254:21-26.
54. Owada Y., Watanabe M., Kondo H. Localization of mRNA for beta-adrenergic receptor kinase in the brain of adult rats. Neuroscience Letters 1992, 144:9-13.
55. Patel A.J., Hunt A., Gordon R.D., Balazs R. The activities in different neural cell types of certain enzymes associated with the metabolic compartmentation glutamate. Brain Research 1982, 256:3-11.
56. Pennypacker K., Fischer I., Levitt P. Early in vitro genesis and differentiation of axons and dendrites by hippocampal neurons analyzed quantitatively with neurofilament-H and microtubule-associated protein 2 antibodies. Experimental Neurology 1991, 111:25-35.
57. Perego C., Fumagalli S., De Simoni M.G. Temporal pattern of expression and colocalization of microglia/macrophage phenotype markers following brain ischemic injury in mice. Journal of Neuroinflammation 2011, 8:174.
58. Pishak M.R., Phillips A.T. A modified radioisotopic assay for measuring glutamine synthetase activity in tissue extracts. Analytical Biochemistry 1979, 94:82-88.
59. Schmuck G., Rohrdanz E., Tran-Thi Q.H., Kahl R., Schluter G. Oxidative stress in rat cortical neurons and astrocytes induced by paraquat in vitro. Neurotoxicity Research 2002, 4:1-13.
60. Schrier B.K., Shuster L. A simplified radiochemical assay for choline acetyltransferase. Journal of Neurochemistry 1967, 14:977-985.
61. Shimizu K., Ohtaki K., Matsubara K., Aoyama K., Uezono T., Saito O., Suno M., Ogawa K., Hayase N., Kimura K., Shiono H. Carrier-mediated processes in blood-brain barrier penetration and neural uptake of paraquat. Brain Research 2001, 906:135-142.
62. Snyder G.A., Sundberg E.J. Molecular interactions in interleukin and toll-like receptor signaling pathways. Current Pharmaceutical Design 2013.
63. Sobolevsky A.I., Rosconi M.P., Gouaux E. X-ray structure, symmetry and mechanism of an AMPA-subtype glutamate receptor. Nature 2009, 462:745-756.
64. Sorci G., Agneletti A.L., Donato R. Effects of S100A1 and S100B on microtubule stability. An in vitro study using triton-cytoskeletons from astrocyte and myoblast cell lines. Neuroscience 2000, 99:773-783.
65. Srinivasan S., Spear J., Chandran K., Joseph J., Kalyanaraman B., Avadhani N.G. Oxidative stress induced mitochondrial protein kinase A mediates cytochrome C oxidase dysfunction. PLoS One 2013, 8:e77129.
66. Sterk M., Oenings A., Eymann E., Roos W. Development of a new automated enzyme immunoassay for the determination of neuron-specific enolase. Anticancer Research 1999, 19:2759-2762.
67. Streit W.J., Conde J.R., Fendrick S.E., Flanary B.E., Mariani C.L. Role of microglia in the central nervous system's immune response. Neurological Research 2005, 27:685-691.
68. Stridh M.H., Alt M.D., Wittmann S., Heidtmann H., Aggarwal M., Riederer B., Seidler U., Wennemuth G., McKenna R., Deitmer J.W., Becker H.M. Lactate flux in astrocytes is enhanced by a non-catalytic action of carbonic anhydrase II. The Journal of Physiology 2012, 590:2333-2351.
69. Suarez I., Bodega G., Fernandez B. Glutamine synthetase in brain: effect of ammonia. Neurochemistry International 2002, 41:123-142.
70. Svensson M., Eriksson N.P., Aldskogius H. Evidence for activation of astrocytes via reactive microglial cells following hypoglossal nerve transection. Journal of Neuroscience Research 1993, 35:373-381.
71. Swisher J.F., Khatri U., Feldman G.M. Annexin A2 is a soluble mediator of macrophage activation. Journal of Leukocyte Biology 2007, 82:1174-1184.
72. Taetzsch T., Block M.L. Pesticides, microglial NOX2, and Parkinson's disease. Journal of Biochemical and Molecular Toxicology 2013, 27:137-149.
73. Takamiya Y., Kohsaka S., Toya S., Otani M., Tsukada Y. Immunohistochemical studies on the proliferation of reactive astrocytes and the expression of cytoskeletal proteins following brain injury in rats. Brain Research 1988, 466:201-210.
74. Tanboon W., Chuchue T., Vattanaviboon P., Mongkolsuk S. Inactivation of thioredoxin-like gene alters oxidative stress resistance and reduces cytochrome c oxidase activity in Agrobacterium tumefaciens. FEMS Microbiology Letters 2009, 295:110-116.
75. Wang A., Costello S., Cockburn M., Zhang X., Bronstein J., Ritz B. Parkinson's disease risk from ambient exposure to pesticides. European Journal of Epidemiology 2011, 26:547-555.
76. Wesley U.V., Vemuganti R., Ayvaci E.R., Dempsey R.J. Galectin-3 enhances angiogenic and migratory potential of microglial cells via modulation of integrin linked kinase signaling. Brain Research 2013, 1496:1-9.
77. Whitton P.S. Neuroinflammation and the prospects for anti-inflammatory treatment of Parkinson's disease. Current Opinion in Investigational Drugs 2010, 11:788-794.
78. Wilson S.H., Schrier B.K., Farber J.L., Thompson E.J., Rosenberg R.N., Blume A.J., Nirenberg M.W. Markers for gene expression in cultured cells from the nervous system. The Journal of Biological Chemistry 1972, 247:3159-3169.
79. Wingo W.J., Awapara J. Decarboxylation of L-glutamic acid by brain. The Journal of Biological Chemistry 1950, 187:267-271.
80. Wu X.F., Block M.L., Zhang W., Qin L., Wilson B., Zhang W.Q., Veronesi B., Hong J.S. The role of microglia in paraquat-induced dopaminergic neurotoxicity. Antioxidants & Redox Signaling 2005, 7:654-661.
81. Zurich M.G., Eskes C., Honegger P., Berode M., Monnet-Tschudi F. Maturation-dependent neurotoxicity of lead acetate in vitro: implication of glial reactions. Journal of Neuroscience Research 2002, 70:108-116.